V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20194557 | 20124622 | 1.6 | 78 | Palliative (P) | 2018-08-30 | 2018-09-13 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101706941 |
| 20194560 | 20124623 | 1.51 | 55.9 | Palliative (P) | 2016-06-25 | 2016-07-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101801745 |
| 20194562 | 20124624 | 1.51 | 66.4 | Palliative (P) | 2018-08-14 | 2018-08-17 | Docetaxel | 02 | N | DOCETAXEL | 101021231 |
| 20194567 | 20124625 | 1.76 | 51.8 | null | 2021-08-02 | 2021-08-08 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 100823562 |
| 20194568 | 20124626 | 1.66 | 64 | Neo-adjuvant (N) | 2016-12-29 | 2017-01-03 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101442055 |
| 20194569 | 20124627 | 1.6 | 48 | null | 2017-05-03 | 2017-06-08 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100582249 |
| 20194570 | 20124628 | 1.49 | 53.8 | Palliative (P) | 2020-09-30 | 2020-10-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100411500 |
| 20194579 | 20124629 | 1.81 | 65.35 | null | 2019-11-23 | 2020-02-02 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100111215 |
| 20194581 | 20124630 | 1.7 | 92 | Palliative (P) | 2016-03-02 | 2016-03-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100719544 |
| 20194583 | 20124631 | 1.63 | 48.8 | Palliative (P) | 2019-03-30 | 2020-02-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100931917 |
| 20194588 | 20124632 | 1.68 | 58.8 | Palliative (P) | 2017-06-09 | 2017-06-28 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101692335 |
| 20194589 | 20124633 | 1.71 | 59.6 | Palliative (P) | 2018-08-18 | 2019-01-27 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101055181 |
| 20194590 | 20124634 | 1.63 | 76.1 | null | 2021-11-29 | 2021-11-30 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100183363 |
| 20194592 | 20124635 | 1.51 | 74.4 | Palliative (P) | 2019-12-09 | 2020-04-25 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100028682 |
| 20194594 | 20124636 | 1.9 | 68.2 | Palliative (P) | 2020-05-26 | 2020-11-04 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101660888 |
| 20194598 | 20124637 | 1.56 | 70 | Palliative (P) | 2016-06-08 | 2016-07-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100860541 |
| 20194599 | 20124638 | 1.6 | 104 | Palliative (P) | 2016-05-26 | 2016-06-02 | Docetaxel | 02 | N | DOCETAXEL | 101800654 |
| 20194603 | 20124639 | 1.85 | 92 | Palliative (P) | 2017-04-28 | 2017-07-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100594754 |
| 20194607 | 20124640 | 1.68 | 67 | Palliative (P) | 2017-10-30 | 2017-10-30 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101041661 |
| 20194608 | 20124641 | 1.52 | 97.4 | Palliative (P) | 2019-07-30 | 2019-08-08 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100027326 |
| 20194609 | 20124642 | 1.7 | 56.1 | Palliative (P) | 2018-01-20 | 2018-01-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 101266657 |
| 20194618 | 20124643 | 1.73 | 106.5 | Palliative (P) | 2019-04-18 | 2019-05-22 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101284341 |
| 20194622 | 20124644 | 1.63 | 71 | Palliative (P) | 2016-03-23 | 2016-03-23 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101051646 |
| 20194623 | 20124645 | 1.6 | 78.5 | null | 2020-03-30 | 2020-04-12 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101834478 |
| 20194624 | 20124646 | 1.67 | 53.3 | null | 2016-09-13 | 2016-09-15 | Cetuximab + FOLFIRI cycle1 | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100714858 |
| 20194629 | 20124647 | 1.66 | 97 | null | 2019-01-15 | 2019-02-03 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101799621 |
| 20194630 | 20124648 | 1.6 | 62.4 | Palliative (P) | 2019-08-15 | 2019-08-17 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100329208 |
| 20194633 | 20124649 | 1.69 | 50.6 | Palliative (P) | 2016-04-01 | 2016-04-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100929962 |
| 20194634 | 20124650 | 1.68 | 65 | null | 2018-04-02 | 2018-04-10 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | DOCETAXEL | 101636356 |
| 20194636 | 20124651 | 1.83 | 50 | Palliative (P) | 2016-04-21 | 2017-01-16 | Cetuximab + FOLFIRI cycle1 | 02 | N | DOCETAXEL | 101448548 |
| 20194637 | 20124652 | 1.6 | 71 | null | 2019-04-06 | 2019-05-09 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100253224 |
| 20194642 | 20124653 | null | 103.1 | Palliative (P) | 2018-08-30 | 2018-09-18 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101836040 |
| 20194645 | 20124654 | 1.7 | 66.4 | Palliative (P) | 2018-03-12 | 2018-03-12 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101603838 |
| 20194646 | 20124655 | 1.74 | 85 | null | 2017-06-14 | 2017-07-09 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101210966 |
| 20194648 | 20124656 | 1.7 | 64 | null | 2018-07-17 | 2018-08-12 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101604049 |
| 20194649 | 20124657 | 1.59 | 89.45 | Adjuvant (A) | 2017-01-25 | 2017-04-18 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101488327 |
| 20194651 | 20124658 | 1.71 | 66.3 | Palliative (P) | 2018-07-18 | 2018-07-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101798275 |
| 20194653 | 20124659 | 1.3 | 53.7 | null | 2018-05-21 | 2018-05-21 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100955567 |
| 20194654 | 20124660 | 1.91 | 70.1 | Adjuvant (A) | 2019-03-08 | 2019-03-22 | CAPECITABINE + GEMCITABINE | N | null | CAPECITABINE + GEMCITABINE | 101710269 |
| 20194656 | 20124661 | 1.85 | 63.35 | null | 2019-10-11 | 2019-11-04 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100930605 |
| 20194658 | 20124662 | 1.89 | 62 | Palliative (P) | null | 2020-11-23 | Docetaxel 75mg/m2 (21 day) | N | N | DOCETAXEL | 101477301 |
| 20194662 | 20124663 | 1.49 | 61.4 | Palliative (P) | 2018-12-20 | 2019-01-07 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101475727 |
| 20194666 | 20124664 | 1.69 | 102.6 | Palliative (P) | 2016-07-15 | 2016-10-21 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101282101 |
| 20194668 | 20124665 | 1.85 | 52.55 | null | 2016-10-23 | 2017-02-07 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100866632 |
| 20194669 | 20124666 | null | null | null | 2018-02-25 | 2018-09-06 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100734143 |
| 20194670 | 20124667 | 0 | 66.4 | Palliative (P) | 2018-05-07 | 2018-12-30 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101286676 |
| 20194672 | 20124668 | 1.6 | 69.6 | Palliative (P) | 2020-01-01 | 2020-01-08 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101005907 |
| 20194677 | 20124669 | 1.7 | 67 | Curative (C) | 2016-05-19 | 2016-05-26 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101195456 |
| 20194680 | 20124670 | 1.69 | 74.8 | Palliative (P) | 2016-06-01 | 2016-06-08 | Docetaxel | N | N | DOCETAXEL | 101045782 |
| 20194685 | 20124671 | 1.61 | 48.7 | Palliative (P) | 2019-07-15 | 2019-10-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100512321 |